Dissolved and financials
CVR: 36557125
DKK 0
Gross profit
Net result: DKK 0
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 29 August 2017
CVR · view overview
No headcount reported
Director role ended: Anders Kjær Larsen
CVR · 15/08/2017
View the full event history
KJÆRS BIOVIN IVS was a Danish company of the type Iværksætterselskab based in Nørresundby, founded in 2015. The company has been dissolved on 29 August 2017. The company was registered under the industry Uoplyst. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2016 report amounted to DKK 0.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201603/02/2015 – 03/02/2016 | 0 | 0 | 0 | 0 | - |
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorNo. KJÆRS BIOVIN IVS is registered in the Danish CVR register with the status Dissolved and ceased on 29 August 2017.
The CVR number of KJÆRS BIOVIN IVS is 36557125.
In 2016, KJÆRS BIOVIN IVS reported a gross profit of DKK 0.
KJÆRS BIOVIN IVS was founded on 3 February 2015.
KJÆRS BIOVIN IVS was registered under the industry Uoplyst (industry code 999999).
KJÆRS BIOVIN IVS was located at Brenning 14, 9400 Nørresundby.
KJÆRS BIOVIN IVS was dissolved on August 29, 2017.
As of August 15, 2017, Anders Kjær Larsen has stepped down as adm. dir of KJÆRS BIOVIN IVS.
KJÆRS BIOVIN IVS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK 0.
As of February 3, 2015, Anders Kjær Larsen is registered as adm. dir of KJÆRS BIOVIN IVS.
KJÆRS BIOVIN IVS was founded on February 3, 2015.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er besidde kapitalandele i datterselskaber og associerede selskaber samt at drive investeringsvirksomhed samt enhver i forbindelse hermed beslægtet virksomhed.
